Resources
3 Results (showing 1 - 3)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 5/27/2020 (updated 3/28/2024)
Please see attached technical modules to help guide you as you work to address the opioid epidemic in your communities. They are a resource for you to identify best practices and implementation models for prevention, treatment, and recovery.
Posted 7/28/2021 (updated 4/2/2024)
The most effective treatments for opioid use disorder (OUD) are the three prescription medications approved by the U.S. Food and Drug Administration (FDA)—methadone, buprenorphine, and naltrexone—that are proved to increase a patient’s treatment retention and reduce illicit use and the risk of overdose. The only facilities legally able to offer all three medications are opioid treatment programs (OTPs), a critical component of the U.S. substance use treatment system that are regulated by the federal Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA), as well as state agencies, and are certified to administer any FDA-approved medication for the treatment of OUD.
Posted 10/21/2020 (updated 4/3/2024)
This study sought to identify best practices for retaining individuals in treatment and for achieving continuity of care between settings.